In France, the current research & development by business enterprise, pharmaceutical industry in constant ppp $ is 881.85 million, which reflects a decrease of 60.80 million (-6.5%) compared to 2019.
Research & development by business enterprise, pharmaceutical industry in constant PPP $ in France
No matching regions
Similar regions to France
Business R&D pharmaceutical in constant PPP $
More indicators for France
Government R&D in security as % of government support
7.6%
+1.49%
(2021)
Higher-education-finacing R&D financed by general university in local currency
36,331.51M
-2,332.69M
(2015)
R&D financed by rest of the world in local currency
42,663.99M
+1,742.43M
(2021)
Government R&D financed by rest of the world in local currency
5,363.60M
-470.20M
(2021)
Business R&D financed by rest of the world in local currency
31,430.09M
+2,892.63M
(2021)
Non-profit R&D growth rate
-1.84%
-10.2%
(2022)
France Business R&D pharmaceutical in constant PPP $ between 2007 and 2020
Period | Business R&D pharmaceutical in constant PPP $ | Change |
---|---|---|
2020 | 881.85M | -60.80M |
2019 | 942.65M | -50.83M |
2018 | 993.48M | -23.12M |
2017 | 1,016.60M | -27.16M |
2016 | 1,043.76M | -53.68M |
2015 | 1,097.44M | +28.11M |
2014 | 1,069.32M | +60.65M |
2013 | 1,008.67M | -15.20M |
2012 | 1,023.87M | -52.57M |
2011 | 1,076.44M | -2.16M |
2010 | 1,078.60M | -38.89M |
2009 | 1,117.49M | -259.86M |
2008 | 1,377.35M | -95.83M |
2007 | 1,473.18M |